Literature DB >> 8347351

Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells.

E A Wang1, D I Israel, S Kelly, D P Luxenberg.   

Abstract

C3H10T1/2 cells are an established mesenchymal stem cell line which can differentiate into muscle, fat and cartilage cells when treated with azacytidine. Bone morphogenetic protein-2 (BMP-2) caused a dose dependent differentiation of these cells into fat, cartilage and bone cells-low concentrations favoring adipocytes and high concentrations chondrocytes and osteoblasts. The differentiated phenotypes were stable in the absence of BMP-2. Furthermore, the addition of other growth factors during the differentiation process altered the frequency of the differentiated colony formation. Transfection of the C3H10T1/2 cells with a BMP-2 cDNA also induced a phenotypic change from the parental fibroblast to adipocytes and osteoblasts. Our results in this model system indicate that a single protein factor can cause differentiation of a stem cell line to multiple phenotypes, that phenotypes induced can be regulated by factor concentration, and that other factors can also influence BMP-2 induced differentiation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8347351     DOI: 10.3109/08977199308991582

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  117 in total

1.  New adipogenic cell lines derived from C3H10T1/2.

Authors:  A Ogawa; K Ohba; Y Uchida; K Wada; T Yoshioka; T Muraki
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-06       Impact factor: 2.416

Review 2.  Growth factor delivery for tissue engineering.

Authors:  J E Babensee; L V McIntire; A G Mikos
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

3.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.

Authors:  David G Winkler; May Kung Sutherland; James C Geoghegan; Changpu Yu; Trenton Hayes; John E Skonier; Diana Shpektor; Mechtild Jonas; Brian R Kovacevich; Karen Staehling-Hampton; Mark Appleby; Mary E Brunkow; John A Latham
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

4.  Perlecan-stimulated nodules undergo chondrogenic maturation in response to rhBMP-2 treatment in vitro.

Authors:  Ronald R Gomes; Mary C Farach Carson; Daniel D Carson
Journal:  Connect Tissue Res       Date:  2003       Impact factor: 3.417

Review 5.  Adipose tissue stem cells meet preadipocyte commitment: going back to the future.

Authors:  William P Cawthorn; Erica L Scheller; Ormond A MacDougald
Journal:  J Lipid Res       Date:  2011-12-02       Impact factor: 5.922

6.  Foxo1, a novel regulator of osteoblast differentiation and skeletogenesis.

Authors:  Cristina C Teixeira; Yuexun Liu; Lwin M Thant; Jason Pang; Glyn Palmer; Mani Alikhani
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

7.  Customized Ca-P/PHBV nanocomposite scaffolds for bone tissue engineering: design, fabrication, surface modification and sustained release of growth factor.

Authors:  Bin Duan; Min Wang
Journal:  J R Soc Interface       Date:  2010-05-26       Impact factor: 4.118

8.  MiR-503 inhibits adipogenesis by targeting bone morphogenetic protein receptor 1a.

Authors:  Xiao-Fei Man; Shu-Wen Tan; Hao-Neng Tang; Yue Guo; Chen-Yi Tang; Jun Tang; Ci-La Zhou; Hou-De Zhou
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

9.  Rat aortic smooth muscle cells cultured on hydroxyapatite differentiate into osteoblast-like cells via BMP-2-SMAD-5 pathway.

Authors:  Pranjal Nahar-Gohad; Neeraj Gohad; Chen-Chih Tsai; Rajendra Bordia; Naren Vyavahare
Journal:  Calcif Tissue Int       Date:  2015-03-01       Impact factor: 4.333

10.  Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis.

Authors:  A Rebbapragada; H Benchabane; J L Wrana; A J Celeste; L Attisano
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.